PREDICTSCRIPT
Live / Registered — Registered (as of 18 Feb 2025)
What this means for you
Registered since 18 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97091070
- Registration number
- 7697879
- Mark type
- Stylized text
- Filed
- 25 Oct 2021
- Published for opposition
- 19 Sept 2023
- Registered
- 18 Feb 2025
- Attorney of record
- ROGER H. BORA
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing
Owner
- Phenomics Health Inc., Plymouth, MI, US
- Phenomics Health Inc., Plymouth, MI, US
- Phenomics Health Inc., Plymouth, MI, US
Prosecution history
- 18 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jan 2025 — ASSIGNED TO LIE
- 13 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Oct 2024 — NON-FINAL ACTION E-MAILED
- 15 Oct 2024 — SU - NON-FINAL ACTION - WRITTEN
- 15 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 13 May 2024 — USE AMENDMENT FILED